论文部分内容阅读
目的:对复发性尿路感染患者的细菌检验与药敏情况进行分析研究。方法:选择我院在2015年7月~2016年7月期间收治的220例复发性尿路感染患者作为此次研究分析的对象,并采集患者中段尿液标本进行培养,随后根据菌落生长的情况给予细菌检验以及药物的敏感性实验,同时观察并统计出病原菌具体分布的情况与耐药性。结果:经检验后,结果显示,有201株菌株,其中革兰氏阴性杆菌及阳性杆菌分别有144株、57株;给予药敏试验后发现对头胞菌素类与丁胺卡那霉素敏感性较强的主要有克雷伯菌、阴沟肠杆菌、铜绿假单胞菌、大肠埃希菌;对氨苄青霉素与三代头胞菌素产生敏感性的主要有金黄色葡萄球菌、链球菌属、肠球菌属等,其中对三代头胞菌素的敏感率在41.32%~51.21%之间,对氨苄青霉素的敏感率仅在31.00%以下。结论:给予复发性尿路感染患者采用正确的细菌检验及药敏试验可发现主要的致病杆菌为革兰氏阴性杆菌,且对不同的病原菌使用不同的抗生素,其敏感性也有所差异,因此,对相关病原菌进行正确的检测及药物的敏感性试验,可为临床医师科学的使用药物及治疗措施的确定提供应用价值较高的依据。
Objective: To analyze the bacterial test and drug susceptibility in patients with recurrent urinary tract infection. Methods: 220 patients with recurrent urinary tract infection admitted from July 2015 to July 2016 in our hospital were selected as the object of this study. Urine specimens from the middle of the patients were collected for culture. Then according to the growth of colonies Give bacteria test and drug sensitivity test, at the same time observe and statistics of the specific distribution of pathogens and drug resistance. Results: After the test, the results showed that there were 201 strains, of which Gram-negative bacilli and positive bacilli were 144 strains, 57 strains; given sensitivity test found that the first-class macrolide and amikacin sensitive The main sex are Klebsiella, Enterobacter cloacae, Pseudomonas aeruginosa, Escherichia coli; ampicillin and the three generation of cephalosporin sensitive mainly Staphylococcus aureus, Streptococcus, Enterococcus, etc., among which the sensitivity to three-generation cephalosporins was between 41.32% and 51.21%, and the sensitivity to ampicillin was only below 31.00%. CONCLUSIONS: Patients with recurrent urinary tract infections can be found to have Gram-negative bacilli by using the correct bacterial tests and susceptibility tests. Different antibiotics are used for different pathogenic bacteria and their sensitivity is different. Therefore, , The correct detection of the relevant pathogens and drug susceptibility testing can provide clinicians a scientific basis for the use of drugs and treatment measures to determine the value of higher.